SRX3177, a CDK4/6-PI3K-BET Inhibitor, in Combination with an RdRp Inhibitor, Molnupiravir, or an Entry Inhibitor MU-UNMC-2, Has Potent Antiviral Activity Against the Omicron Variant of SARS-CoV-2
Antiviral Research（2024）
关键词
Triple inhibitor,SRX3177,RdRp inhibitor,Entry inhibitor,Combinatorial,SARS-CoV-2,Omicron,MU-UNMC-2
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要